Genomic characterization of HER2-positive breast cancer and response to neoadjuvant trastuzumab and chemotherapy-results from the ACOSOG Z1041 (Alliance) trial

R. Lesurf, O. L. Griffith, M. Griffith, J. Hundal, L. Trani, M. A. Watson, R. Aft, M. J. Ellis, D. Ota, V. J. Suman, F. Meric-Bernstam, A. M. Leitch, J. C. Boughey, G. Unzeitig, A. U. Buzdar, K. K. Hunt, E. R. Mardis

Research output: Contribution to journalArticlepeer-review

26 Scopus citations

Fingerprint

Dive into the research topics of 'Genomic characterization of HER2-positive breast cancer and response to neoadjuvant trastuzumab and chemotherapy-results from the ACOSOG Z1041 (Alliance) trial'. Together they form a unique fingerprint.

Immunology and Microbiology

Keyphrases

Biochemistry, Genetics and Molecular Biology